Please use this identifier to cite or link to this item:
|Title:||Progress in osteoporosis and fracture prevention: focus on postmenopausal women||Authors:||Saag, Kenneth G.
|Issue Date:||2009||Publisher:||BIOMED CENTRAL LTD||Source:||ARTHRITIS RESEARCH & THERAPY, 11(5)||Abstract:||In the past decade, we have witnessed a revolution in osteoporosis diagnosis and therapeutics. This includes enhanced understanding of basic bone biology, recognizing the severe consequences of fractures in terms of morbidity and short-term refracture and mortality risk and case finding based on clinical risks, bone mineral density, new imaging approaches, and contributors to secondary osteoporosis. Medical interventions that reduce fracture risk include sufficient calcium and vitamin D together with a wide spectrum of drug therapies (with antiresorptive, anabolic, or mixed effects). Emerging therapeutic options that target molecules of bone metabolism indicate that the next decade should offer even greater promise for further improving our diagnostic and treatment approaches.||Notes:||[Saag, Kenneth G.] Univ Alabama, Div Clin Immunol & Rheumatol, Ctr Educ & Res Therapeut, Birmingham, AL 35294 USA. [Geusens, Piet] Maastricht Univ, Med Ctr, Dept Internal Med, Subdiv Rheumatol, NL-6202 AZ Maastricht, Netherlands. [Geusens, Piet] Univ Hasselt, Biomed Res Inst, B-3590 Diepenbeek, Belgium. firstname.lastname@example.org||Document URI:||http://hdl.handle.net/1942/10432||ISSN:||1478-6362||DOI:||10.1186/ar2815||ISI #:||000273338400018||Category:||A1||Type:||Journal Contribution||Validations:||ecoom 2011|
|Appears in Collections:||Research publications|
Show full item record
Files in This Item:
|geusens.pdf||Published version||1.11 MB||Adobe PDF||View/Open|
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.